Table 2.

Landmark survival for all indications

Survival	Metastatic breast cancer	Metastatic non-small cell lung cancer	Metastatic colorectal cancer	Metastatic ovarian cancer	Metastatic malignant melanoma
Median survival (months, 95% CI)	20 (19.4, 20.6)	5.18 (5.1, 5.3)	12.8 (12.6, 13.1)	23.4 (22.0, 24.9)	7.4 (6.8, 7.9)
1-year survival (%, 95% CI)	61 (60.4, 61.9)	25.4 (24.8, 26.0)	51.8 (51.1, 52.4)	69 (66.9,71.1)	38.9 (37.4, 40.4)
5-year survival (%, 95% CI)	21.6 (20.9, 22.3)	3.2 (3.0, 3.6)	15.1 (15.0, 16.0)	20.3 (18.3, 22.5)	15.6 (14.4, 16.9)
10-year survival (%, 95% CI)	10 (9.4, 10.7)	1.7 (1.4, 2.0)	10 (9.5, 10.5)	10.3 (8.54, 12.5)	10.6 (9.4, 12.1)